Mandibular Metastasis as a Rare Presentation of Follicular Variant Papillary Thyroid Carcinoma: A Case Series
DOI:
https://doi.org/10.20956/nmsj.v10i2.48914Abstract
Introduction: Papillary thyroid carcinoma (PTC) is the most common endocrine malignancy. The follicular variant of papillary thyroid carcinoma (FV-PTC) represents a distinct histologic subtype that tends to spread hematogenously to distant organs, including bone. Mandibular metastasis from FV-PTC is exceedingly rare and may pose a diagnostic challenge, particularly when it precedes recognition of the primary thyroid lesion. Presentation of case: We report two Asian female patients presenting with mandibular masses. The first patient had a history of total thyroidectomy for papillary thyroid carcinoma (follicular variant) ten years earlier. Imaging revealed an extensive osteolytic lesion of the right mandible. Histopathology of an incisional biopsy confirmed metastatic PTC, and the patient underwent right hemimandibulectomy with immediate reconstruction using a titanium plate. The second patient presented with a large, painful left mandibular mass without any history or clinical evidence of thyroid disease. Imaging showed a destructive lytic lesion of the left mandible, while neck ultrasonography revealed no thyroid enlargement. Biopsy suggested FV-PTC of thyroid origin. The patient underwent left hemimandibulectomy with titanium plate reconstruction. Final histopathology in both cases confirmed FV-PTC metastasis to the mandible. Conclusion: Mandibular metastasis from FV-PTC is a rare manifestation that may occur as late recurrence after thyroidectomy or as the first indication of an occult thyroid carcinoma. Comprehensive diagnostic workup and appropriate surgical reconstruction are crucial to achieve local disease control and preserve function. Clinicians should consider metastatic thyroid carcinoma in the differential diagnosis of lytic mandibular lesions, even in the absence of a palpable thyroid
References
1. Salih A, Qaradakhy A, Abdullah A, et al. Papillary thyroid cancer in prepubertal patients: A report of two cases and a brief review of the literature. Med Int. 2025;5(6):1-8. doi:10.3892/mi.2025.273
2. Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229-263. doi:10.3322/caac.21834
3. Jeon EJ, Jeong YJ, Park SH, Cho CH, Shon HS, Jung ED. Ultrasonographic Characteristics of the Follicular Variant Papillary Thyroid Cancer According to the Tumor Size. J Korean Med Sci. 2016;31(3):397. doi:10.3346/jkms.2016.31.3.397
4. Cabanillas ME, McFadden DG, Durante C. Thyroid cancer. Lancet Lond Engl. 2016;388(10061):2783-2795. doi:10.1016/S0140-6736(16)30172-6
5. Filetti S, Durante C, Hartl D, et al. Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†. Ann Oncol Off J Eur Soc Med Oncol. 2019;30(12):1856-1883. doi:10.1093/annonc/mdz400
6. Nervo A, Ragni A, Retta F, et al. Bone metastases from differentiated thyroid carcinoma: current knowledge and open issues. J Endocrinol Invest. 2021;44(3):403-419. doi:10.1007/s40618-020-01374-7
7. Butar EYB, Prihantono P, Hendra FN, Faruk M. A Systematic Review And Meta-Analysis Comparing The Prognoses Of Benign Thyroid Nodules Using Radiofrequency Ablation Versus Lobectomy. Asian Pac J Cancer Prev APJCP. 2025;26(8):2699-2707. doi:10.31557/APJCP.2025.26.8.2699
8. Li YD, Ye QY, Chen YX, Hu XR. Thyroid Cancer: Pathogenesis, Clinicopathology, Diagnosis, and Management. MedComm. 2025;6(11):e70449. doi:10.1002/mco2.70449
9. Brahma B, Yulian ED, Ramli M, et al. Surgical perspective of T1799A BRAF mutation diagnostic value in papillary thyroid carcinoma. Asian Pac J Cancer Prev APJCP. 2013;14(1):31-37. doi:10.7314/apjcp.2013.14.1.31
10. Bozkurt H, İrkörücü O, Aziret M, Reyhan E, Okuyan MK. Comparison of 1869 thyroid ultrasound-guided fine-needle aspiration biopsies between general surgeons and interventional radiologists. Ann Med Surg 2012. 2016;10:92-102. doi:10.1016/j.amsu.2016.07.015
11. Kakudo K, Bychkov A, Bai Y, Li Y, Liu Z, Jung CK. The new 4th edition World Health Organization classification for thyroid tumors, Asian perspectives. Pathol Int. 2018;68(12):641-664. doi:10.1111/pin.12737
12. Iñiguez-Ariza NM, Bible KC, Clarke BL. Bone metastases in thyroid cancer. J Bone Oncol. 2020;21:100282. doi:10.1016/j.jbo.2020.100282
13. Chen S, Lei J, Mou H, et al. Multiple influence of immune cells in the bone metastatic cancer microenvironment on tumors. Front Immunol. 2024;15:1335366. doi:10.3389/fimmu.2024.1335366
14. Shin HS, Sun HJ, Whang YM, Park YJ, Park DJ, Cho SW. Metformin Reduces Thyroid Cancer Tumor Growth in the Metastatic Niche of Bone by Inhibiting Osteoblastic RANKL Productions. Thyroid. 2021;31(5):760-771. doi:10.1089/thy.2019.0851
15. Anajar S, Hassnaoui J, Rouadi S, Abada R, Roubal M, Mahtar M. Mandibular metastasis revealed papillary thyroid carcinoma: Rare case. Int J Surg Case Rep. 2017;37:130-133. doi:10.1016/j.ijscr.2017.05.001
16. Li D, Li J, Zhou J, Xiao Q, Gao H. Metastatic papillary thyroid carcinoma with no primary tumor in the thyroid gland: a case report and review of literature. Transl Cancer Res. 2022;11(1):299-305. doi:10.21037/tcr-21-1780
17. Wareing J, Dawoud B, Power A, Sutton D. Intrabony mandibular metastases caused by papillary thyroid carcinoma masquerading as a parotid swelling. Ann R Coll Surg Engl. 2021;103(8):e264-e265. doi:10.1308/rcsann.2020.7091
18. Shah JP. Thyroid carcinoma: epidemiology, histology, and diagnosis. Clin Adv Hematol Oncol HO. 2015;13(4 Suppl 4):3-6.
19. Lin JD, Hsueh C, Chao TC. Long-Term Follow-Up of the Therapeutic Outcomes for Papillary Thyroid Carcinoma With Distant Metastasis. Medicine (Baltimore). 2015;94(26):e1063. doi:10.1097/MD.0000000000001063
20. Cascio V, Doerfler WR, Taneja C. Diagnosis and management of brain metastasis from thyroid cancer. Endocr Oncol. 2025;5(1):e250002. doi:10.1530/EO-25-0002
21. Ito Y, Miyauchi A, Kihara M, Fukushima M, Higashiyama T, Miya A. Overall Survival of Papillary Thyroid Carcinoma Patients: A Single-Institution Long-Term Follow-Up of 5897 Patients. World J Surg. 2018;42(3):615-622. doi:10.1007/s00268-018-4479-z
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 William Hamdani, Erwin A. Patabang, Haryasena Haryasena , Djonny Ferianto, John Pieter Jr., Salman Ardi Syamsu

This work is licensed under a Creative Commons Attribution 4.0 International License.







